// App-Quantinova.ai

1073 : FLT3-ITD As a Target for Minimal Residual Disease Monitoring in Early T-Cell Precursor (ETP) Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Nellina Andriano

Principal Investigators

  • Barbara Buldini

  • Daniela Silvestri

  • Giuseppe Basso

  • Luca Lo Nigro

  • Giovanni Cazzaniga

  • Tiziana Villa

  • Franco Locatelli

  • Rosanna Parasole

  • Elena Barisone

  • Anna Maria Testi

  • Andrea Biondi

  • Maria Grazia Valsecchi

  • Valentino Conter

Medical Centers

  • Clinica Pediatrica, Universit degli studi di Milano-Bicocca, Fondazione MBBM/Ospedale S. Gerardo, Monza, Italy

  • Department of Pediatrics, Ospedale Infantile Regina Margherita, University of Torino, Torino, Italy, Torino, Italy

  • Center of Pediatric Hematology Oncology, Azienda Policlinico - University of Catania, Catania, Italy

  • Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy

  • Pediatric Hematology/Oncology, IRCCS Bambino Ges Childrens Hospital Rome, University of Pavia, Rome, Italy

  • Centro di Biostatistica per lepidemiologia clinica, Department of Health Sciences, Universit di Milano Bicocca, Monza, Italy

  • Department of Womens and Childrens Health, Laboratory of Oncohematology, University of Padua, Padua, Italy

  • Pediatric Hematology Unit, Santobono-Pausilipon Hospital, Naples, Italy

  • Centro di Ricerca M.Tettamanti, Clinica Pediatrica, Universit degli studi di Milano-Bicocca, Fondazione MBBM/Ospedale S. Gerardo, Monza,

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved